Filing Details

Accession Number:
0001104659-16-121861
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-05-18 16:02:48
Reporting Period:
2016-05-16
Filing Date:
2016-05-18
Accepted Time:
2016-05-18 16:02:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1501134 Invitae Corp NVTA Services-Medical Laboratories (8071) 271701898
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1627771 Patty Dumond C/O Invitae Corporation
458 Brannan Street
San Francisco CA 94107
Vp Fin. & Principal Acct. Off. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-05-16 1,000 $2.82 12,033 No 4 M Direct
Common Stock Disposition 2016-05-16 1,000 $8.73 11,033 No 4 S Direct
Common Stock Disposition 2016-05-17 2,221 $8.35 8,812 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2016-05-16 1,000 $0.00 1,000 $2.82
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
9,333 2023-09-11 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b 5-1 trading plan previously adopted by the reporting person.
  2. Includes 2,221 shares of the Company's Common Stock acquired pursuant to the Company's Employee Stock Purchase Plan.
  3. Represents a weighted average purchase price for multiple transactions at prices ranging from $7.94 to $8.77, inclusive. Upon request by the Commission staff, the Company or a security holder of the Company, the reporting person will provide full information regarding the number of shares purchased by the reporting person on May 17, 2016 at each separate price.
  4. The option became exercisable as to 25% of the shares on September 11, 2014, and becomes exercisable as to 1/48th of the shares each full month thereafter.